Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Cipla
Johnson and Johnson
McKesson
Moodys

Generated: April 20, 2018

DrugPatentWatch Database Preview

Akorn Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AKORN INC, and what generic and branded alternatives to AKORN INC drugs are available?

AKORN INC has thirty-three approved drugs.

There are three tentative approvals on AKORN INC drugs.

Summary for Akorn Inc
US Patents:0
Tradenames:30
Ingredients:30
NDAs:33

Drugs and US Patents for Akorn Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 090163-001 Jun 24, 2009 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION/DROPS;OPHTHALMIC 207926-002 Jan 15, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up
Akorn Inc APRACLONIDINE HYDROCHLORIDE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 077764-001 Mar 12, 2009 AT RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065305-003 Jan 11, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Deloitte
Accenture
Argus Health
Merck
AstraZeneca
Federal Trade Commission
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.